Inventor · disambiguated record
David Clark
Also filed as: CLARK DAVID · CLARK DAVID A · CLARK DAVID ALEXANDER
20 granted patents·6 pending applications·515 citations·filing 1999–2023
96Inventor score
Files withTRILLIUM THERAPEUTICS INC11NEOGEN CORP4CLARK ROBIN D2CORCEPT THERAPEUTICS INC2TRANSPLANTATION TECHNOLOGIES I2
Top patents by PatentIndex Score
26 records- 0197US7238352B2Methods and compositions for modulating tumor growthTRILLIUM THERAPEUTICS INC·Filed 2005·Granted Jul 3, 2007·43 cites·5 claims
- 0296US7887798B2Methods of treating cancer by administering antibodies to CD200TRILLIUM THERAPEUTICS INC·Filed 2008·Granted Feb 15, 2011·20 cites·12 claims
- 0396US6955811B2Methods of inhibiting immune response suppression by administering antibodies to OX-2TRILLIUM THERAPEUTICS INC·Filed 2001·Granted Oct 18, 2005·51 cites·9 claims
- 0495US7452536B2Methods of treating cancer by administering antibodies to CD200TRILLIUM THERAPEUTICS INC·Filed 2007·Granted Nov 18, 2008·23 cites·19 claims
- 0594US7902151B2Methods and compositions for modulating immunityTRILLIUM THERAPEUTICS INC·Filed 2009·Granted Mar 8, 2011·19 cites·15 claims
- 0694US7678813B2Azadecalin Glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Mar 16, 2010·42 cites·21 claims
- 0793US7576076B2Modified pyrimidine glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Aug 18, 2009·48 cites·12 claims
- 0893US6749854B2Use of OX-2 to inhibit fetal lossTRILLIUM THERAPEUTICS INC·Filed 2001·Granted Jun 15, 2004·41 cites·12 claims
- 0993US6652858B2Use of OX-2 to suppress an immune responseTRILLIUM THERAPEUTICS INC·Filed 2001·Granted Nov 25, 2003·39 cites·13 claims
- 1091US6881554B2Apparatus and methods for chemiluminescent assaysNEOGEN CORP·Filed 2003·Granted Apr 19, 2005·39 cites·8 claims
- 1191US6548018B2Apparatus for chemiluminescent assaysNEOGEN CORP·Filed 2001·Granted Apr 15, 2003·40 cites·21 claims
- 1290US8324203B2Azadecalin glucocorticoid receptor modulatorsCLARK ROBIN D·Filed 2010·Granted Dec 4, 2012·22 cites·5 claims
- 1390US6887681B2Apparatus and methods for chemiluminescent assaysNEOGEN CORP·Filed 2003·Granted May 3, 2005·36 cites·7 claims
- 1484US8173664B2Modified pyrimidine glucocorticoid receptor modulatorsCLARK ROBIN D·Filed 2009·Granted May 8, 2012·11 cites·11 claims
- 1584US7485262B2Apparatus for chemiluminescent assaysNEOGEN CORP·Filed 2002·Granted Feb 3, 2009·20 cites·13 claims
- 1674US2024036061A1Methods for the diagnosis and treatment of endometriosisUNIV MCMASTER·Filed 2023·Application pending·0 cites
- 1768US7291330B2MD-1 inhibitors as immune suppressantsTRILLIUM THERAPEUTICS INC·Filed 2001·Granted Nov 6, 2007·3 cites·3 claims
- 1868US6403089B1Methods of modulating immune coagulationTRANSPLANTATION TECHNOLOGIES I·Filed 1999·Granted Jun 11, 2002·18 cites·4 claims
- 1964US11719707B2Methods for the diagnosis and treatment of endometriosisUNIV MCMASTER·Filed 2020·Granted Aug 8, 2023·0 cites·5 claims
- 2062US7553811B2Methods and compositions for modulating immunityTRILLIUM THERAPEUTICS INC·Filed 2007·Granted Jun 30, 2009·0 cites·2 claims
- 2159US2005169913A1Compositions comprising antibodies to human FgI2TRILLIUM THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 2259US2007128198A1Compositions comprising antibodies to human fgl2LEVY GARY·Filed 2007·Application pending·0 cites
- 2357US8187598B2Methods of treating cancer by administering antibodies to CD200GORCZYNSKI REGINALD M·Filed 2011·Granted May 29, 2012·0 cites·8 claims
- 2457US2011206668A1Methods and compositions for modulating immunityTRILLIUM THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 2551US2003103974A1Methods of modulating immune coagulationTRANSPLANTATION TECHNOLOGIES I·Filed 2002·Application pending·0 cites
- 2637US2012017707A1Systems and methods for detecting objects in the groundJACKSON RONALD SCOTT·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →